Nxera Pharma Co Ltd (SOLTF)
9.55
+0.25
(+2.65%)
USD |
OTCM |
May 03, 16:00
Nxera Pharma Cash and Short Term Investments (Quarterly): 350.16M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 350.16M |
| September 30, 2023 | 285.93M |
| June 30, 2023 | 455.19M |
| March 31, 2023 | 497.97M |
| December 31, 2022 | 507.63M |
| September 30, 2022 | 423.45M |
| June 30, 2022 | 393.56M |
| March 31, 2022 | 484.66M |
| December 31, 2021 | 522.90M |
| September 30, 2021 | 445.98M |
| June 30, 2021 | 368.27M |
| March 31, 2021 | 366.93M |
| December 31, 2020 | 387.92M |
| September 30, 2020 | 357.70M |
| June 30, 2020 | 142.77M |
| March 31, 2020 | 151.15M |
| December 31, 2019 | 141.19M |
| September 30, 2019 | 192.01M |
| June 30, 2019 | 156.77M |
| March 31, 2019 | 166.90M |
| September 30, 2018 | 187.59M |
| June 30, 2018 | 226.58M |
| March 31, 2018 | 266.12M |
| December 31, 2017 | 285.06M |
| September 30, 2017 | 110.34M |
| Date | Value |
|---|---|
| June 30, 2017 | 115.89M |
| March 31, 2017 | 124.31M |
| December 31, 2016 | 132.76M |
| September 30, 2016 | 154.90M |
| June 30, 2016 | 200.85M |
| March 31, 2016 | 89.58M |
| December 31, 2015 | 99.09M |
| September 30, 2015 | 46.06M |
| June 30, 2015 | 56.03M |
| March 31, 2015 | 46.43M |
| December 31, 2014 | 65.83M |
| September 30, 2014 | 69.40M |
| June 30, 2014 | 72.93M |
| March 31, 2014 | 70.11M |
| December 31, 2013 | 31.38M |
| September 30, 2013 | 22.75M |
| June 30, 2013 | 23.08M |
| March 31, 2013 | 26.95M |
| December 31, 2012 | 27.90M |
| September 30, 2012 | 13.82M |
| June 30, 2012 | 15.18M |
| March 31, 2012 | 18.20M |
| December 31, 2011 | 18.94M |
| September 30, 2011 | 15.50M |
| June 30, 2011 | 17.91M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
141.19M
Minimum
Dec 2019
522.90M
Maximum
Dec 2021
349.06M
Average
368.27M
Median
Jun 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 2.251B |
| PeptiDream Inc | 138.37M |
| Stemcell Holdings Inc | 5.116M |
| Healios KK | 47.67M |
| AnGes Inc | 29.50M |